# Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

> **NCT05133310** · PHASE4 · UNKNOWN · sponsor: **Hospital General de Mexico** · enrollment: 108 (estimated)

## Conditions studied

- Strains
- Acute Lymphoblastic Leukemia
- Sepsis

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT05133310
- **Lead sponsor:** Hospital General de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-19
- **Primary completion:** 2022-12-16
- **Final completion:** 2023-06-23
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133310, "Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05133310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*